Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -1701.4% | -1168.7% |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 178.7 | 88.6 |
Pr/Book | 4.5 |
Latest | F'cast | |
---|---|---|
Revenue | 32.9% | 101.7% |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Apr-18 | 0.63 | (8.93) | (7.91)p | n/a | n/a | n/a | n/a | 0.0% |
30-Apr-19 | 0.68 | (10.87) | (6.56)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-19 | 0.58 | (9.04) | (6.88)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | 0.76 | (13.74) | (6.52)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 1.01 | (17.36) | (6.67)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-22 | 2.04 | (23.87) | (8.68)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 5.96 | (25.34) | (9.32)p | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2022 FactSet Research Systems Inc. All rights reserved.
Novel insight into metastasis in NSCLC patients | 28-Jul-2022 | 07:00 | RNS |
Holding(s) in Company | 20-Jul-2022 | 14:33 | RNS |
NEW STUDY OF PARSORTIX SYSTEM IN NSCLC | 20-Jul-2022 | 07:00 | RNS |
New Angle for Braveheart | 26-Jan-2009 | The Scotsman |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
19-Jul-22 | Buy | Ian F Griffiths | 80.00p | 37,500 | £30,000.00 |
19-Jul-22 | Buy | Andrew D Newland | 80.00p | 125,000 | £100,000.00 |
Currency | UK Pounds |
Share Price | 69.50p |
Change Today | -1.00p |
% Change | -1.42 % |
52 Week High | 156.00 |
52 Week Low | 69.10 |
Volume | 403,291 |
Shares Issued | 260.49m |
Market Cap | £181.04m |
RiskGrade | 312 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
17:06 | 15,000 @ 69.50p |
16:33 | 1,877 @ 69.60p |
16:32 | 6,862 @ 69.60p |
16:25 | 2,862 @ 69.60p |
16:17 | 10,000 @ 69.65p |
CEO | Andrew D Newland |
Finance Director | Ian F Griffiths |
Chair | Garth Selvey |
You are here: research